Category Archives: Alice

The Twelve §101 Precedential Decisions of 2017

This is a guest post from the Chisum Patent Academy. In 2017, Federal Circuit panels regularly addressed attacks on software patent claims as ineligible under the Alice “abstract idea” exception. The 2017 pattern, with 8 of 10 decisions finding software … Continue reading

Posted in Alice, Federal Court | Leave a comment

Ex Parte Patterson: Assay Based on Two “Natural Phenomena” Does Not Equal One “Inventive Concept”

According to the “Mayo/Alice” rule, if a claim is directed to a “natural phenomena” such as the relationship between the a drug’s metabolite concentration following administration of an immunosuppressive drug and the therapeutic window of efficacy of the drug, the claim … Continue reading

Posted in Alice, Appeals, Obviousness, Section 101 | Tagged , , , | Leave a comment

Sixteen Critical 2016-2017 Patentability & Validity Developments

This is a guest post from Donald Chisum and Janice Mueller of the Chisum Patent Academy. Below are highlights of the Critical  Patentability & Validity Developments of 2016-2017.   The Federal Circuit’s January 2017 decision in Sonix Tech. Co. v. Publications Int’l, … Continue reading

Posted in 102 Patentability, Alice, Appeals, Assignment/Ownership, Claim Interpretation, Federal Court, Infringement, Post-Grant Issues, USPTO Practice and Policy | Leave a comment

Mallinckrodt v. Praxair – Innomax Method Patent Fails Alice/Mayo Test

On Tuesday, a Delaware district court judge ruled that a group of Mallinckrodt patents failed the Alice/(mostly)Mayo test as claiming a natural phenomenon. The patents are directed to a method of safely using the Innomax system, which administers nitric oxide to infants … Continue reading

Posted in Alice, Federal Court, Uncategorized | 1 Comment